In toxicology, the balance between sensitivity and specificity is critical. A highly sensitive biomarker may produce false positives, while a highly specific biomarker may miss some exposures. Therefore, toxicologists aim to develop biomarkers with an optimal balance, providing reliable results that can inform risk assessments and regulatory decisions.
